Paavo J. Sr Riekkinen
#164,422
Most Influential Person Now
Paavo J. Sr Riekkinen's AcademicInfluence.com Rankings
Paavo J. Sr Riekkinenbiology Degrees
Biology
#13230
World Rank
#16764
Historical Rank
Molecular Biology
#2212
World Rank
#2246
Historical Rank
Biochemistry
#2300
World Rank
#2448
Historical Rank
Download Badge
Biology
Why Is Paavo J. Sr Riekkinen Influential?
(Suggest an Edit or Addition)Paavo J. Sr Riekkinen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease' (1998) (548)
- Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia (1996) (445)
- Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. (1985) (310)
- MRI of the Hippocampus in Alzheimer’s Disease: Sensitivity, Specificity, and Analysis of the Incorrectly Classified Subjects (1998) (281)
- Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age‐associated memory impairment (1994) (280)
- Subjective Memory Complaints and Personality Traits in Normal Elderly Subjects (1994) (236)
- The significance of intensity of rehabilitation of stroke--a controlled trial. (1985) (232)
- Neurotransmitter changes in alzheimer's disease: Implications to diagnostics and therapy (1990) (224)
- Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study (1994) (218)
- Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects (1999) (189)
- Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes (1995) (189)
- Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in alzheimer's disease (1995) (183)
- Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland (1995) (174)
- Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study. (1995) (173)
- The cholinergic system and EEG slow waves. (1991) (162)
- The cholinergic system and EEG slow waves. (1991) (162)
- Prevalence of ageing-associated cognitive decline in an elderly population. (1996) (157)
- A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein ε4 allele (1995) (153)
- The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease (1997) (151)
- Longitudinal EEG spectral analysis in early stage of Alzheimer's disease. (1989) (149)
- A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease (1988) (147)
- Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ϵ4 allele (1995) (136)
- Decline of Frontal Lobe Functions in Subjects with Age-associated Memory Impairment (1997) (132)
- SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. (1996) (132)
- Essential hypertension and cognitive function. The role of hyperinsulinemia. (1993) (131)
- Hippocampus in Alzheimer’s disease: a 3-year follow-up MRI study (2000) (120)
- Cross-cultural studies of dementia. A comparison of mini-mental state examination performance in Finland and China. (1989) (117)
- Delirium among elderly persons admitted to a psychiatric hospital: clinical course during the acute stage and one‐year follow‐up (1989) (115)
- Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up (1992) (113)
- Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease (1996) (107)
- Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type (1984) (107)
- Computed tomography findings in senile dementia and normal aging. (1982) (99)
- Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. (1995) (98)
- Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study (1996) (96)
- The association of apolipoprotein E polymorphism with memory: a population based study (1995) (93)
- European Stroke Prevention Study 2. Efficacy and safety data. (1997) (88)
- Homovanillic acid and 5‐hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type (1981) (84)
- Apolipoprotein E, memory and Alzheimer's disease (1996) (84)
- Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder (1995) (84)
- Aging and spectral analysis of EEG in normal subjects: a link to memory and CSF AChE (1992) (83)
- Severity of hippocampal atrophy correlates with the prolongation of MRI T sub 2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease (1996) (78)
- Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques. (1973) (76)
- Apolipoprotein E polymorphism in patients with different neurodegenerative disorders (1996) (75)
- Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome. (1991) (72)
- CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease (1998) (67)
- Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease. (1987) (66)
- Diabetes mellitus and brain atrophy: A computed tomography study in an elderly population (1992) (64)
- Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease (1992) (63)
- Different error pattern of episodic and semantic memory in Alzheimer's disease and Parkinson's disease with dementia (1989) (63)
- Verbal learning and memory in newly diagnosed partial epilepsy (1995) (62)
- Type‐2 diabetes and cognitive function in a non‐demented population (1999) (60)
- Studies on the Pathogenesis of Multiple Sclerosis (1971) (60)
- Hippocampal atrophy is related to impaired memory, but not frontal functions in non‐demented Parkinson's disease patients (1998) (60)
- Vigabatrin in drug‐resistant partial epilepsy (1991) (59)
- Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain. (1996) (59)
- MRI of amygdala fails to diagnose early Alzheimer's disease. (1995) (59)
- Memory and attention in newly diagnosed epileptic seizure disorder (1992) (57)
- The incidence of stroke in the Kuopio area of East Finland. (1985) (57)
- Place of Newer Antiepileptic Drugs in the Treatment of Epilepsy (1993) (57)
- ACID PROTEINASE ACTIVITY OF WHITE MATTER AND PLAQUES IN MULTIPLE SCLEROSIS (1970) (56)
- Imaging of D2 dopamine receptors of patients with Parkinson's disease using single photon emission computed tomography and iodobenzamide I 123. (1993) (53)
- Electromyographic and nerve conduction findings in a patient with neuromyotonia, normocalcemic tetany and small‐cell lung cancer (1980) (53)
- Population-Based Dementia Screening Program in Kuopio: The Effect of Education, Age, and Sex on Brief Neuropsychological Tests (1992) (53)
- A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. (1995) (52)
- MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment (1996) (52)
- Alzheimer pathology of patients carrying apoliprotein E ϵ4 allele (1995) (52)
- Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease (1987) (52)
- ESTERASE, PEPTIDASE AND PROTEINASE ACTIVITIES OF HUMAN CEREBROSPINAL FLUID IN MULTIPLE SCLEROSIS (1968) (51)
- Amyloid β-protein deposition in skin of patients with dementia (1992) (50)
- EEG and CT findings in patients with panic disorder (1990) (50)
- The effects of carbamazepine and sodium valproate on SEPs and BAEPs. (1987) (50)
- Proteinase activity of myelin. (1969) (50)
- Slow-wave activity in the spectral analysis of the electroencephalogram and volumes of hippocampus in subgroups of Alzheimer's disease patients. (1996) (49)
- Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy (1996) (49)
- Penetration of DGAVP (Org 5667) across the blood-brain barrier in human subjects (1987) (49)
- A prospective study of delirium in elderly patients admitted to a psychiatric hospital (1993) (48)
- Purification and characteristics of an alkaline protease from rat-submandibular gland. (1966) (47)
- OPTIC NEURITIS—A SIGN OF MULTIPLE SCLEROSIS OR OTHER DISEASES OF THE CENTRAL NERVOUS SYSTEM (1974) (46)
- Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease (1991) (46)
- Slow-wave activity in the spectral analysis of the electroencephalogram is associated with cortical dysfunctions in patients with Alzheimer's disease. (1991) (46)
- Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls (1996) (46)
- Spectral analysis of EEG in Alzheimer's disease: Relation to apolipoprotein E polymorphism (1996) (45)
- Postoperative EEG and Electrocorticography: Relation to Clinical Outcome in Patients with Temporal Lobe Surgery (1994) (45)
- Androgen-dependent salivary gland protease in the rat. (1968) (44)
- Electrophysiologic Effects of γ‐Vinyl GABA and Carbamazepine (1989) (43)
- Different patterns of cognitive decline related to normal or deteriorating EEG in a 3‐year follow‐up study of patients with Alzheimer's disease (1991) (43)
- Cognitive and memory deficits in untreated Parkinson's disease and amyotrophic lateral sclerosis patients: A comparative study (1993) (43)
- Protein composition of multiple sclerosis myelin. (1971) (42)
- Apolipoprotein E polymorphism and Alzheimer's disease in Eastern Finland (1995) (42)
- Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients (1998) (41)
- Visual Evoked Potentials, Brainstem Auditory Evoked Potentials, and Quantitative EEG in Baltic Progressive Myoclonus Epilepsy (1986) (41)
- Extrapyramidal signs in Alzheimer's disease: A 3-year follow-up study (1992) (41)
- CSF corticotropin-releasing factor is not affected in panic disorder (1993) (40)
- Brain glutamic acid decarboxylase activity in Parkinson's disease. (1974) (40)
- Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group. (1997) (39)
- Predictors of seizure outcome in newly diagnosed partial epilepsy: memory performance as a prognostic factor (1999) (39)
- Randomized Controlled Pilot Study of Vigabatrin Versus Carbamazepine Monotherapy in Newly Diagnosed Patients With Epilepsy: An Interim Report (1991) (38)
- MRI-based hippocampal volumetry and T2 relaxometry: correlation to verbal memory performance in newly diagnosed epilepsy patients with left-sided temporal lobe focus. (1997) (38)
- Interaction between dopamine and phospholipids. Studies of the substantia nigra in Parkinson disease patients. (1975) (37)
- Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study. (1993) (37)
- Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains (1997) (36)
- Studies on the pathogenesis of multiple sclerosis. 2',3'-Cyclic nucleotide 3-phosphohydrolase as marker of demyelination and correlation of findings with lysosomal changes. (1972) (36)
- Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia. (1986) (36)
- Mice with an aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients. (1998) (35)
- A critical evaluation of myelin purification. Non-specific esterase activity associated with central nerve myelin preparations. (1970) (33)
- Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease (1998) (33)
- Cholinergic deficit in Alzheimer's disease: A study based on CSF and autopsy data (1988) (32)
- Age-related cognitive decline and electroencephalogram slowing in down's syndrome as a model of Alzheimer's disease (1993) (32)
- Four isozymic forms of a peptidase resembling kallikrein purified from the rat submandibular gland. (1967) (31)
- The interuncal distance in Alzheimer disease and age-associated memory impairment. (1995) (31)
- Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease. (1995) (30)
- Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease. (1995) (30)
- Increased acetylcholinesterase activity in the CSF of Alzheimer patients carrying apolipoprotein epsilon4 allele. (1995) (30)
- Neurotransmitter markers in the cerebrospinal fluid of normal subjects effects of aging and other confounding factors (2005) (29)
- EEG and computed tomography in the investigation of patients with senile dementia. (1982) (29)
- STABILITY OF AGE‐ASSOCIATED MEMORY IMPAIRMENT DURING A LONGITUDINAL POPULATION‐BASED STUDY (1997) (29)
- Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus (1991) (29)
- Psychometric discrimination of tetrahydroaminoacridine responders in Alzheimer patients. (1993) (28)
- Electrophysiological and neuropsychological effects of a central alpha2-antagonist atipamezole in healthy volunteers (1993) (27)
- SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E £4 allele (27)
- Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele. (1995) (27)
- COMPUTED TOMOGRAPHY FINDINGS IN SENILE DEMENTIA AND NORMAL AGING (1982) (26)
- Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue. (1999) (26)
- β-Endorphin-like immunoreactivity in cerebrospinal fluid of patients with Alzheimer's disease and Parkinson's disease (1987) (26)
- Slowing of the dominant occipital rhythm in electroencephalogram is associated with low concentration of noradrenaline in the thalamus in patients with Alzheimer's disease (1992) (26)
- Biochemical and fine structural studies on brain and liver biopsies in aspartylglucosaminuria (1971) (26)
- Prolonged cortical somatosensory evoked potential latencies in progressive myoclonus epilepsy (1984) (25)
- A new neutral proteinase from the rat brain. (1968) (25)
- Cerebrospinal fluid somatostatin correlates with spectral EEG variables and with parietotemporal cognitive dysfunction in Alzheimer patients (1988) (24)
- Spectral EEG During Short‐Term Discontinuation of Antiepileptic Medication in Partial Epilepsy (1995) (24)
- BRAIN ACETYLCHOLINESTERASE IN PARKINSON'S DISEASE (1973) (24)
- Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease (1987) (24)
- Further studies on neutral proteinase activity of CNS myelin. (1970) (23)
- Regional cerebral blood flow measured by99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease (1995) (23)
- Prolonged Latencies of Pattern Reversal Visual Evoked Early Potentials in Alzheimer Disease (1994) (22)
- Electrophysiologic effects of gamma-vinyl GABA and carbamazepine. (1989) (22)
- Maturation of myelin proteins in human brain. (1972) (22)
- Guillan-Barré Syndrome (1971) (22)
- Somatostatin and cognitive functions in Alzheimer's disease — the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine (1991) (21)
- beta-Amyloid protein immunoreactivity in skin is not a reliable marker of Alzheimer's disease. An autopsy-controlled study. (1994) (21)
- Dopaminergic nervous transmission in Parkinson's disease. (1974) (20)
- Three‐year follow‐up of patients with panic disorder after short‐term treatment with alprazolam and imipramine (1993) (20)
- Studies on the alkaline trypsin-like enzymes in rat submandifular gland and saliva. (1967) (20)
- Decreased somatostatin-like immunoreactivity in the cerebrospinal fluid of chronic schizophrenic patients with cognitive impairment (1990) (20)
- ERPs reveal deficits in automatic cerebral stimulus processing in patients with NIDDM. (1996) (20)
- The importance of the electrocardiogram in ambulatory electroencephalographic recordings. (1989) (19)
- Electronystagmographic findings in multiple sclerosis. (1973) (19)
- Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease (2005) (19)
- Risk factors and antiplatelet therapy in TIA and stroke patients (1998) (17)
- Recent progress in the research of Alzheimer's disease. (1987) (17)
- No association between α 1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease (1997) (17)
- Acute confusional states in the elderly: A radiological evaluation (1987) (17)
- Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder (1995) (17)
- Differences in Memory Impairment in Patients with Alzheimer’s Disease and Parkinson’s Disease with and without Dementia (1990) (17)
- Cholinesterase activities in the autonomic nervous system of rabbits with experimental allergic neuritis: A biochemical study (1983) (17)
- 2′,3′-Cyclic nucleotide-3′-phosphodiesterase activity as an index of myelin in the post-mortem brains of patients with Alzheimer's disease (1989) (16)
- Increased aspartate aminotransferase activity in cerebrospinal fluid and Alzheimer's disease (1998) (16)
- Purification and physical characteristics of a trypsin-like protease from the rat submandibular gland. (1967) (15)
- Cerebrospinal fluid somatostatin in delirium (1989) (15)
- Regulation of EEG delta activity by the cholinergic nucleus basalis (1989) (15)
- Substrate specificity and modifier characteristics of an alkaline protease from the rat submandibular gland: glandulain. (1967) (14)
- RETROBULBAR NEURITIS AS AN EARLY SYMPTOM OF GUILLAIN‐BARRE SYNDROME (1972) (14)
- Involvement of autonomic nervous system in experimental allergic neuritis A light- and electron-microscopic study (1982) (13)
- DGAVP (Org 5667) in early Alzheimer's disease patients (1990) (13)
- Cognitive profile of Alzheimer patients with extrapyramidal signs: A longitudinal study (1992) (13)
- The depressor activity of trypsin-like enzymes purified from rat submandibular gland. (1967) (13)
- LYSOSOMAL ENZYMES IN THE LYMPHOCYTES AND GRANULOCYTES OF PATIENTS WITH MULTIPLE SCLEROSIS (1977) (13)
- Proteinases in human cerebrospinal fluid. (1968) (13)
- Amyloid beta-protein deposition in skin of patients with dementia. (1992) (13)
- Dementia without cholinergic deficit. (1987) (13)
- Preoperative EEG predicts memory and selective cognitive functions after temporal lobe surgery. (1995) (13)
- Chemical pathology of multiple sclerosis. (1973) (12)
- Epileptic attack, delirium, and a Creutzfeldt-Jakob-like syndrome during mianserin treatment. (1990) (12)
- Enzyme and protein studies of demyelination in diabetes (1977) (12)
- Pathogenesis of Multiple Sclerosis (1976) (12)
- Chronic Anticonvulsive Therapy, Peripheral Nerve Conduction Velocity, and EMG (1981) (12)
- Peptidase activity of myelin during the myelination period in guinea-pig brain. (1970) (12)
- Critical evaluation of the postmortem factors influencing neurochemical analyses of brain autopsies (1980) (12)
- Esterase activity in purified myelin preparations from beef brain. (1969) (11)
- Effects of L-tryptophan treatment on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis (2005) (11)
- Cerebrospinal fluid somatostatin in delirium. II Changes at the acute stage and at one year follow-up (1990) (11)
- Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome (1993) (11)
- CSF beta-endorphin-like immunoreactivity in delirium (1989) (10)
- PEPTIDASE ACTIVITY OF PURIFIED MYELIN (1970) (10)
- Myelin breakdown and basic protein. (1974) (10)
- DGAVP (Org 5667) in early Alzheimer??s disease patients: an international double-blind, placebo-controlled multicenter trial (1991) (10)
- KALLIKREIN‐LIKE ESTERASE AND PEPTIDASE ACTIVITIES IN CSF DURING MIGRAINE ATTACKS AND FREE INTERVALS (1972) (9)
- HOMOVANILLIC ACID AND 5-HYDROXYINDOLEACETIC ACID LEVELS IN CEREBROSPINAL FLUID OF PATIENTS WITH SENILE DEMENTIA OF ALZHEIMER TYPE (1980) (9)
- Tetrahydroaminoacridine modulates technetium-99m labelled ethylene dicysteinate retention in Alzheimer's disease measured with single photon emission computed tomography imaging (1995) (9)
- Cholinesterase activities in the somatic nervous system of rabbits with experimental allergic neuritis (1983) (8)
- Protein composition of white matter myelin in subacute sclerosing panencephalitis (1971) (8)
- The effect of ACTH4-9 analog (Org2766) on some cerebrospinal fluid parameters in patients with Alzheimer's disease. (1985) (8)
- beta-Endorphin-like immunoreactivity in cerebrospinal fluid of patients with Alzheimer's disease and Parkinson's disease. (1987) (8)
- A family with autosomal dominant spinocerebellar ataxia, with electrophysiological findings. (1973) (7)
- Neurochemical and morphological studies on demyelination in multiple sclerosis with special reference to etiological aspects (2004) (7)
- Does an ACTH derivative (Org 2766) prevent deterioration of EEG in Alzheimer's disease? (1986) (7)
- Aspartylglucosaminuria II: biochemical studies on brain, liver, kidney and spleen (2004) (7)
- Neuronal Ceroid-Lipofuscinosis (1973) (7)
- Long-term treatment with vigabatrin – 10 years of clinical experience (1999) (6)
- Circulating immune complexes in sera from patients with Alzheimer's disease and subjects with age-associated memory impairment (1993) (6)
- Electron microscopic and neurochemical studies on demyelination in subacute sclerosing panencephalitis. (1972) (6)
- Neurotransmitters in Senile Dementia of Alzheimer Type and in Vascular Dementia1 (1985) (6)
- Aspartylglucosaminuria I: fine structural studies on liver, kidney and brain (2004) (6)
- Demonstration of a proteolytic enzyme, salivain, in rat saliva. (1966) (6)
- Monoclonal gammopathy with neurological signs and symptoms (1982) (6)
- Wide Third Ventricle Correlates with Low Choline Acetyltransferase Activity of the Neocortex in Alzheimer Patients (1993) (6)
- Epileptic attack, delirium, and periodic complexes in the EEG during mianserin treatment. (1991) (5)
- STUDIES IN THE SALIVARY GLANDS. I. TRYPSIN-LIKE ENZYMES. (1965) (5)
- A longitudinal study of cerebrospinal fluid acetylcholinesterase in delirium: Changes at the acute stage and at one-year followup (1991) (5)
- Maturational changes of CNS myelin with special reference to neutral proteinase activities. (1972) (5)
- Electroneuromyographic findings in patients with Alzheimer's disease. (1991) (5)
- Biochemical and fine structural studies in aspartylglucosaminuria. (1972) (5)
- Short biotinylated oligonucleotides bind non-specifically to senile plaques of Alzheimer's disease (1991) (4)
- Monoclonal gammopathy with neurological signs and symptoms. A clinical, neurophysiological and muscle biopsy study. (1982) (4)
- STUDIES IN THE SALIVARY GLANDS. II. HYDROLYSIS OF CHROMOGENIC ESTER SUBSTRATES. (1965) (4)
- The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients (1997) (4)
- THE EFFECT OF SMALL DOSE OF ALDOSE REDUCTASE INHIBITOR (SORBINIL) ON DIABETIC NEUROPATHY (1984) (4)
- Fractionation of peptidase and esterase activities of human cerebrospinal fluid. (1968) (4)
- Topographic analysis of MS and control brains. (1978) (4)
- Short‐term withdrawal of antiepileptic medication: effects on attention and memory (1995) (4)
- No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease. (1997) (3)
- Pathogenesis of multiple sclerosis. Neurochemical and morphological studies on MS biopsies and autopsies. (1976) (3)
- Poststroke depression and rehabilitation outcome (1993) (3)
- Delirium and the DST in the aged (1987) (3)
- Studies on the pathogenesis of multiple sclerosis. Basic proteins in the myelin and white matter of multiple sclerosis, subacute sclerosing panencephalitis and postvaccinal leucoencephalitis. (1971) (3)
- [Studies on esterolytic enzymes of human parotid saliva]. (1966) (3)
- ULTRASTRUCTURAL STUDIES OF MULTIPLE SCLEROSIS BRAIN BIOPSIES (1970) (3)
- Retrospective study of 117 patients with optic neuritis. (1974) (3)
- Neuronal ceroid-lipofuscinosis. Report of two cases with neurochemical and morphological observations. (1973) (2)
- Electrophysiological signs of peripheral nerve dysfunction in progressive myoclonus epilepsy (1981) (2)
- CHEMICAL AND ENZYMATIC STUDIES ON THE COMPOSITION OF THE WHITE MATTER IN MULTIPLE‐SCLEROSIS BRAINS (1970) (2)
- [Regulation of attention]. (1993) (2)
- Guillan-Barré syndrome. Neurochemical and ultrastructural study. (1971) (2)
- Section Review Central & Peripheral Nervous Systems: New anti-epileptic drugs (1995) (2)
- Observations in a family with dominant type of cerebellar ataxia. (1972) (2)
- Efficacy of a 1- to 3-day ambulatory electroencephalogram in recording epileptic seizures. (1990) (2)
- Immunosuppressive therapy in neurological diseases. (1974) (2)
- Peripheral nerves as target tissue of the immune response in EAN. A neurochemical and morphological study. (1978) (1)
- Vigabatrin treatment of epilepsy (1991) (1)
- Panic disorder in the differential diagnosis of temporal lobe epilepsy (1990) (1)
- Main Results of the European Stroke Prevention Study (ESPS) (1987) (1)
- 672 Longitudinal study of CSF amyloid proteins and apoE in patients with Alzheimer's disease (1996) (1)
- Cerebrospinal fluid erythrophages and iron containing cells in cerebrovascular diseases. (1972) (1)
- Association of Intrusion Error with Early Clinical Diagnosis of Alzheimer's Disease (1987) (1)
- MORPHOLOGICAL AND BIOCHEMICAL STUDIES ON LIVER BIOPSIES OF PARKINSONIAN PATIENTS TREATED WITH LEVODOPA AND DECARBOXYLASE INHIBITOR (1974) (1)
- [Symptoms of Creutzfeldt-Jakob disease during mianserin therapy]. (1991) (1)
- PROTEIN AND GANGLIOSIDE COMPOSITION OF HUMAN CENTRAL NERVOUS SYSTEM MYELIN (1970) (1)
- A chymotrypsin-like protease from the rat submandibular gland. (1966) (1)
- Hormonal influences on leucine aminopeptidase in the accessory reproductive tracts of the rat (1962) (1)
- [Subacute sclerosing panencephalitis in an adult]. (1988) (1)
- Studies on esterolytic enzymes from human parotid saliva. (1966) (1)
- immunoreactivity inthe cerebrospinal fluid ofpatients withParkinson's disease andits relation todementia (1986) (1)
- 579 Efficacy and safety of selegiline in the long-term treatment of patients with Alzheimer's disease (1996) (1)
- CRITICAL RE‐EVALUATION OF THE PURIFICATION METHODS OF MYELIN BY USING QUANTITATIVE MORPHOMETRIC AND CHEMICAL ANALYSES (1970) (1)
- Proteinase and peptidase activities of human cerebrospinal fluid in multiple sclerosis. (2009) (1)
- Biochemical correlations in autoimmune target tissue lesions of GBS and EAN. (1980) (0)
- Frontal Dysfunction and Memory Deficit in Depression and Parkinson’s Disease (1995) (0)
- ENZYME ACTIVITIES OF THE SUBCELLULAR FRACTIONS OF MYELIN IN THE DEVELOPING GUINEA‐PIG BRAIN (1970) (0)
- Auditory P300 in untreated epilepsy (1993) (0)
- 51. Dopamine and homovanillic acid concentrations and monoamine oxidase-B activities in the brain tissue of patients with Alzheimer's disease (1987) (0)
- 94. A clinical study with desglycinamide arginine vasopressine (DGAVP) in (S)DAT: methods and results (1987) (0)
- Screening for amyloid beta precursor protein codon 665, 670 671 and 717 mutations in Finnish patients with Alzheimer's disease (1996) (0)
- [Quantitative EEG in various forms of Alzheimer's disease]. (1984) (0)
- Subject Index Vol. 21, 1989 (2004) (0)
- Alzheimer's disease and multi-infarct dementia differ in their neuropsychological and EEG correlations (1993) (0)
- Cerebrospinal fluid beta-endorphin-like immunoreactivity in patients with dementia associated with schizophrenia and chronic alcoholism (1991) (0)
- Somatosensory Evoked Potential Dynamics in Baltic Progressive Myoclonus Epilepsy (1988) (0)
- Long-term cognitive effects of tiagabine (1997) (0)
- Responders and Nonresponders in Experimental Therapy of Alzheimer’s Disease (1991) (0)
- EEG in the Diagnosis of Early Alzheimer Disease (2020) (0)
- Rationale to Treat Alzheimer’s Disease with Selegiline — Can We Prevent the Progression of the Disease? (1997) (0)
- Postoperative EEG studies: Relation to clinical outcome in patients with temporal lobe surgery (1993) (0)
- 4-12-06 Amyloid beta protein (AB) deposition in the brain: AB42 predominates over AB40 (1997) (0)
- Comparative study of routine EEG, ambulatory EEG and videotelemetry in patients with intractable seizures (1990) (0)
- 210 Non-attentional event-related potentials in age-associated memory impairment (1996) (0)
- [Sinus arrest in a patient with sleep apnea syndrome associated with an increase in alertness]. (1992) (0)
- Testing for mutations in exon 17 of the β-amyloid precursor protein gene in Finnish Alzheimer patients and normal subjects (1994) (0)
- 5-17-12 Hippocampal and amygdalar MRI volumetry and memory scores during vigabatrin monotherapy (1997) (0)
- HEREDITARY PRESSURE SENSITIVE NEUROPATHY (1982) (0)
- Carbamazepine monotherapy versus polytherapy in chronic epilepsies (1984) (0)
- Beta-amyloid load in temporal cortex of patients fulfilling CERADcriteria for probable and definite Alzheimer's disease (1999) (0)
- Apoe Genotype and MRI volumetry: Implication for Therapy (1997) (0)
- Proten composition of white matter myelin in subacute sclerosing panencephalitis. (1971) (0)
- Lipid composition on substantia nigra in Parkinson's disease. (1972) (0)
- Demyelination in subacute sclerosing panencephalitis. Ultrastructural and neurochemical observations. (1972) (0)
- 33. Qualitatively different memory deficit in Alzheimer and Parkinson dementia (1987) (0)
- A neutral trypsin-like protease from the rat submandibular gland. (1966) (0)
- [Guillain-Barré syndrome and its treatment]. (1981) (0)
- Vigabatrin and Carbamazepine Monotherapy for Newly Diagnosed Epilepsy-Reply (1996) (0)
- Basic (encephalitogenic) proteins as vulnerable part in early myelin breakdown. (1972) (0)
- 484 Apolipoprotein E allelic variation and receptor interaction in Alzheimer disease (1996) (0)
- Studies on gamma-vinyl-GABA in Kuopio, Finland. (1988) (0)
- 230 Genetic study of familial Alzheimer's disease in Eastern Finland (1996) (0)
- 463 Neuropsychological correlations of EEG reactivity in alzheimer's disease (1998) (0)
- [The role of neurotransmitters in the pathogenesis and treatment of Alzheimer's disease]. (1983) (0)
- Acetylcholinesterase activity of different brain areas in Parkinson's disease. (1972) (0)
- Apoe and Memory in Alzheimer’s Disease (1998) (0)
- Foerfarande Foer detection of the protein. (1990) (0)
- EEG-videotelemetry of epileptic patients in Vaajasalo hospital, Finland (1985) (0)
- DECREASED AMOUNT OF AXONALLY TRANSPORTED AChE ACTIVITY IN EAN (1980) (0)
- The effect of para-aminosalicylic acid (PAS), isoniazid (INH) and 2-ethylisothionicotinamide (TH1314) on the activity of the thyroid gland of the rat. (1962) (0)
- A new neutral proteinase from the rat brain. (2009) (0)
- NONSPECIFIC CHOLINESTERASE ACTIVITIES IN THE PERIPHERAL NERVES OF RABBITS WITH EXPERIMENTAL ALLERGIC NEURITIS (1980) (0)
- 461 A MRI study of hippocampal atrophy in Parkinson's disease and vascular dementia (1996) (0)
- Correlates of memory in patients with alzheimer's disease and age-associated memory impairment: A spect study (1997) (0)
- ApoE and memory in old age (1997) (0)
- The role of beta‐endorphin and related peptides in the pathogenesis and treatment of Alzheimer's disease (1990) (0)
- 540 Cholinergic function and apolipoprotein E polymorphism in Alzheimer's disease (1996) (0)
- 597 Apolipoprotein E ε4 allele as a risk gene for early changes in temporal lobe structures — MRI volumetric and cognitive changes (1996) (0)
- Immune system response in Down's syndrome and Alzheimer's disease (1992) (0)
- Two-Day Ambulatory EEG/EKG Is Sufficient to Detect Seizures (1988) (0)
- MRI-based Hippocampal Volumetry and T sub 2 Relaxometry (1997) (0)
- Clinical features of progressive and relapsing types of idiopathic polyneuritis. (1972) (0)
- Biochemical studies of CNS and PNS in human and experimental diabetes. (1978) (0)
- Fractionation of proteolytic enzymes of human cerebrospinal fluid. (2009) (0)
This paper list is powered by the following services:
